Nano Science and Technology Institute

Australia-Based Company Begins Sales of Exclusive Human Proteins to Global Research Reagents Market

Apollo Life Sciences is the first and only company in the global reagents market to offer an array of commercialized proteins expressed solely from human cells rather than from rodent or traditional bacteria cells. Proteins from other sources, such as bacteria or insects, have different attachments and behave differently in both experiments and in the human body. Apollo’s proteins are unique because they have human attachments, and thus perform like proteins in the human body. Researchers that use human proteins for their work will now be better able to both simulate human effects and predict the outcomes of clinical trials. The worldwide protein reagents market is estimated at $400 million US per year and includes pharmaceutical companies, university researchers, and hospitals.

↑ Back to Nano World Breaking News™

↑ Back to Nano World News™

Nano World News™ Issue Archive:

RSS feed RSS feed

© 2014 Nano Science and Technology Institute. All Rights Reserved.
Terms of Use | Privacy Policy | Contact Us | Site Map